ASH: InnoCare Upbeat About BCL2 Inhibitor Mesutoclax In MCL

With China Pivotal Trial Data Expected in 2026

The 67th American Society of Hematology (ASH) congress takes place in Orlando, Florida. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from ASH

More from Conferences